U.S. markets closed
  • S&P Futures

    3,453.00
    +3.75 (+0.11%)
     
  • Dow Futures

    28,292.00
    +24.00 (+0.08%)
     
  • Nasdaq Futures

    11,673.00
    +23.25 (+0.20%)
     
  • Russell 2000 Futures

    1,633.20
    +2.60 (+0.16%)
     
  • Crude Oil

    40.73
    +0.09 (+0.22%)
     
  • Gold

    1,907.90
    +3.30 (+0.17%)
     
  • Silver

    24.76
    +0.06 (+0.23%)
     
  • EUR/USD

    1.1804
    -0.0022 (-0.19%)
     
  • 10-Yr Bond

    0.8480
    +0.0320 (+3.92%)
     
  • Vix

    28.11
    -0.54 (-1.88%)
     
  • GBP/USD

    1.3074
    -0.0006 (-0.05%)
     
  • USD/JPY

    104.7100
    -0.1300 (-0.12%)
     
  • BTC-USD

    12,980.96
    +1,923.95 (+17.40%)
     
  • CMC Crypto 200

    261.73
    +5.63 (+2.20%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,523.95
    +49.68 (+0.21%)
     

Can DarioHealth (NASDAQ:DRIO) Afford To Invest In Growth?

Simply Wall St
·4 mins read

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since 1999, you would have made a fortune. But while the successes are well known, investors should not ignore the very many unprofitable companies that simply burn through all their cash and collapse.

Given this risk, we thought we'd take a look at whether DarioHealth (NASDAQ:DRIO) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at which an unprofitable company spends cash to fund its growth; its negative free cash flow. We'll start by comparing its cash burn with its cash reserves in order to calculate its cash runway.

View our latest analysis for DarioHealth

When Might DarioHealth Run Out Of Money?

A company's cash runway is the amount of time it would take to burn through its cash reserves at its current cash burn rate. In December 2019, DarioHealth had US$20m in cash, and was debt-free. In the last year, its cash burn was US$16m. So it had a cash runway of approximately 15 months from December 2019. While that cash runway isn't too concerning, sensible holders would be peering into the distance, and considering what happens if the company runs out of cash. Depicted below, you can see how its cash holdings have changed over time.

NasdaqCM:DRIO Historical Debt April 18th 2020
NasdaqCM:DRIO Historical Debt April 18th 2020

How Well Is DarioHealth Growing?

Some investors might find it troubling that DarioHealth is actually increasing its cash burn, which is up 37% in the last year. At least the revenue was up 2.2% during the period, even if it wasn't up by much. Considering both these factors, we're not particularly excited by its growth profile. While the past is always worth studying, it is the future that matters most of all. So you might want to take a peek at how much the company is expected to grow in the next few years.

How Easily Can DarioHealth Raise Cash?

DarioHealth seems to be in a fairly good position, in terms of cash burn, but we still think it's worthwhile considering how easily it could raise more money if it wanted to. Generally speaking, a listed business can raise new cash through issuing shares or taking on debt. One of the main advantages held by publicly listed companies is that they can sell shares to investors to raise cash to fund growth. We can compare a company's cash burn to its market capitalisation to get a sense for how many new shares a company would have to issue to fund one year's operations.

DarioHealth's cash burn of US$16m is about 83% of its US$19m market capitalisation. That suggests the company may have some funding difficulties, and we'd be very wary of the stock.

So, Should We Worry About DarioHealth's Cash Burn?

On this analysis of DarioHealth's cash burn, we think its cash runway was reassuring, while its cash burn relative to its market cap has us a bit worried. After looking at that range of measures, we think shareholders should be extremely attentive to how the company is using its cash, as the cash burn makes us uncomfortable. Taking a deeper dive, we've spotted 4 warning signs for DarioHealth you should be aware of, and 1 of them is potentially serious.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies insiders are buying, and this list of stocks growth stocks (according to analyst forecasts)

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Thank you for reading.